Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Medtronic
QuintilesIMS
Chinese Patent Office
Dow
Express Scripts
Cantor Fitzgerald
Julphar
Novartis

Generated: February 21, 2018

DrugPatentWatch Database Preview

Catalent Company Profile

« Back to Dashboard

What is the competitive landscape for CATALENT, and what generic and branded alternatives to CATALENT drugs are available?

CATALENT has one approved drug.



Summary for Catalent
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Catalent

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Catalent VALPROIC ACID valproic acid CAPSULE;ORAL 073229-001 Oct 29, 1991 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Cipla
Farmers Insurance
Covington
Johnson and Johnson
Moodys
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot